161 related articles for article (PubMed ID: 23377187)
1. Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses.
Peng HK; Chen WC; Lee JC; Yang SY; Tzeng CC; Lin YT; Yang SC
Org Biomol Chem; 2013 Mar; 11(11):1858-66. PubMed ID: 23377187
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC
Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909
[TBL] [Abstract][Full Text] [Related]
3. Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus.
Tsay SC; Hwu JR; Singha R; Huang WC; Chang YH; Hsu MH; Shieh FK; Lin CC; Hwang KC; Horng JC; De Clercq E; Vliegen I; Neyts J
Eur J Med Chem; 2013 May; 63():290-8. PubMed ID: 23501114
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents.
Hwu JR; Singha R; Hong SC; Chang YH; Das AR; Vliegen I; De Clercq E; Neyts J
Antiviral Res; 2008 Feb; 77(2):157-62. PubMed ID: 17977606
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates.
Neyts J; De Clercq E; Singha R; Chang YH; Das AR; Chakraborty SK; Hong SC; Tsay SC; Hsu MH; Hwu JR
J Med Chem; 2009 Mar; 52(5):1486-90. PubMed ID: 19193060
[TBL] [Abstract][Full Text] [Related]
7. Coumarin-purine ribofuranoside conjugates as new agents against hepatitis C virus.
Hwu JR; Lin SY; Tsay SC; De Clercq E; Leyssen P; Neyts J
J Med Chem; 2011 Apr; 54(7):2114-26. PubMed ID: 21375337
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatitis C virus activity of 3-hydroxy caruilignan C from Swietenia macrophylla stems.
Wu SF; Lin CK; Chuang YS; Chang FR; Tseng CK; Wu YC; Lee JC
J Viral Hepat; 2012 May; 19(5):364-70. PubMed ID: 22497816
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs.
Matsuno K; Ueda Y; Fukuda M; Onoda K; Waki M; Ikeda M; Kato N; Miyachi H
Bioorg Med Chem Lett; 2014 Sep; 24(17):4276-80. PubMed ID: 25086684
[TBL] [Abstract][Full Text] [Related]
10. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
[TBL] [Abstract][Full Text] [Related]
13. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
[TBL] [Abstract][Full Text] [Related]
15. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2.
Lee JC; Chen WC; Wu SF; Tseng CK; Chiou CY; Chang FR; Hsu SH; Wu YC
Antiviral Res; 2011 Jan; 89(1):35-42. PubMed ID: 21075144
[TBL] [Abstract][Full Text] [Related]
16. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
17. Anti-HCV activities of selective polyunsaturated fatty acids.
Leu GZ; Lin TY; Hsu JT
Biochem Biophys Res Commun; 2004 May; 318(1):275-80. PubMed ID: 15110784
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J
J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
